Does LORLATINIB Cause Low density lipoprotein increased? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Low density lipoprotein increased have been filed in association with LORLATINIB (Lorbrena). This represents 1.4% of all adverse event reports for LORLATINIB.
78
Reports of Low density lipoprotein increased with LORLATINIB
1.4%
of all LORLATINIB reports
12
Deaths
15
Hospitalizations
How Dangerous Is Low density lipoprotein increased From LORLATINIB?
Of the 78 reports, 12 (15.4%) resulted in death, 15 (19.2%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
Which LORLATINIB Alternatives Have Lower Low density lipoprotein increased Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE